| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.080 | Biomarker | disease | BEFREE | It is considered that miRNA de-regulation contributes to tumor progression and metastasis in various cancers, and MiR-203a has been identified as a tumor suppressor in cancers, such as glioma, gastric cancer and hepatocellular carcinoma. | 30509104 | 2019 | ||||
|
0.080 | Biomarker | disease | BEFREE | We consider that lncRNA ANRIL is a potential therapeutic and diagnostic target for glioma, and miR-203a plays an important role in the biological function of lncRNA ANRIL in glioma. | 30197521 | 2018 | ||||
|
0.080 | Biomarker | disease | BEFREE | Silencing of lncRNA CCDC26 Restrains the Growth and Migration of Glioma Cells In Vitro and In Vivo via Targeting miR-203. | 28600863 | 2018 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | In this study, we investigated the effect of miR-203 expression and bufalin treatment on glioma cell proliferation and stem cell-like phenotypes. | 29169175 | 2017 | ||||
|
0.080 | Biomarker | disease | BEFREE | Taken together, we show that miR-203 is a key negative regulator of GAS41 and acts as tumor suppressor microRNA in glioma. | 27467502 | 2016 | ||||
|
0.080 | Biomarker | disease | BEFREE | MiR-203 sensitizes glioma cells to temozolomide and inhibits glioma cell invasion by targeting E2F3. | 25515700 | 2015 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | Real-time reverse transcription polymerase chain reaction (RT-PCR) showed that the expression of miR-203 in high WHO grade glioma tissues was significantly decreased compared with low WHO grade glioma tissues and normal brain tissues, and its expression demonstrated a decreasing tendency with ascending WHO grades. | 24270883 | 2014 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | The expression of miR-203 was reduced in high WHO grade glioma tissues compared with that in low WHO grade and normal brain tissues, and decreased with ascending tumor WHO grades (P < 0.001). | 23813496 | 2013 |